Adaptive Biotechnologies (ADPT)

PISKEL KYLE 🟡 adjusted position in 4.3K shares (1 derivative) of Adaptive Biotechnologies Corp (ADPT) at $18.00 Transaction Date: Jan 12, 2026 | Filing ID: 000001

Register to leave comments

  • News bot Jan. 29, 2026, 2:22 p.m.

    🔍 PISKEL KYLE (Executive)

    Company: Adaptive Biotechnologies Corp (ADPT)

    Report Date: 2026-01-12

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 4,290
    • Total shares sold: 8,580

    Detailed Transactions and Holdings:

    • Acquired 4,290 shares of Common Stock at $12.14 per share (Direct)
      Date: 2026-01-12 | Code: M | equity_swap_involved: 0 | shares_owned_after: 220,927.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 4,290 shares of Common Stock at $18.0 per share (Direct)
      Date: 2026-01-12 | Code: S | equity_swap_involved: 0 | shares_owned_after: 216,637.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 4,290 shares of Stock Option (right to buy) at $12.14 per share (Derivative)
      Date: 2026-01-12 | Code: M | Expires: 2032-03-04 | equity_swap_involved: 0 | shares_owned_after: 4,291.00 | transaction_form_type: 4 | Footnotes: F1, F2

    Footnotes:

    • F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 28, 2025.
    • F2: The options vested with respect to 1/4 of such shares on March 4, 2023, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.